— Solution · Biologics →

Biologics

Protein and antibody programs from design through bioprocess, characterization, stability and Certificate of Analysis — wet lab and dry lab on one graph.

01Design
02Upstream / downstream
03Characterization
04Stability
05Release

Design and execution on the same record

Sequence design, construct registration and lab execution share one platform — the designed molecule and the material made from it are connected, not filed separately. Antibody design, bioassays and gels are captured against the construct and the lot.

Bioprocess development tracks upstream and downstream steps with their parameters and equipment. Analytical characterization — chromatography, SDS-PAGE, flow cytometry — parses to one model and binds to the sample. Stability studies schedule their own time points, and the Certificate of Analysis is assembled from records with an unbroken chain back to the material.

What’s connected

Design — sequences, constructs, antibody design, registration
Bioprocess — upstream and downstream steps, critical process parameters, equipment
Characterization — chromatography, gels, flow cytometry, dose-response and potency assays
Stability — ICH-referenced protocols, time points, trending, shelf-life prediction
Release — result schemas, OOS, Certificate of Analysis

See it on the platform: Research · Lab & QC · Manufacturing.

In the product

Antibody design with CDR-level humanization and developability checks — Humanize a sequence and check its developability, CDR by CDR — then register the construct.

Plasmid map viewer with restriction sites — Vectors as governed records: a GenBank file becomes a circular and linear map with in-app editing.

Microplate section with typed well roles — Plate-based assays with typed well roles, layout import and reader-file mapping.

Stability study scheduled from an ICH Q1A protocol — Stability studies schedule their own time points; pull dates create work-queue tasks.

Book a walkthrough All solutions →